Innovations in artificial skin, soft actuators, CRISPR enzymes, nanoelectronic scaffolds, antimicrobial assays, machine learning and more

Technique has potential to help reverse the most common type of disease-associated mutations

Second annual Harvard FUSION symposium explores the Science and Business of Combating Antibiotic Resistance

Agreement supports collaborative advancement of research in a range of therapeutic areas by researchers from across Harvard